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ABSTRACT
MicroRNAs (miRNAs, miRs) are genomically
encoded small ~22nt RNA molecules that have
been shown to mediate translational repression of
target mRNAs involved in cellular proliferation, dif-
ferentiation and death. Despite intensive studies
on their physiological and pathological functions,
the molecular mechanism of how miRNA gene tran-
scription is regulated remains largely unknown.
Microarray profiling revealed 21 miRNAs clustered
on chromosome 12, including miR-433 and miR-
127, that were co-upregulated in small heterodimer
partner (SHP, NR0B2) SHP knockouts (SHP
–/–) liver.
Gene cloning revealed that the 3’-coding region of
pri-miR-433 served as the promoter region of pri-
miR-127. Estrogen related receptor (ERRc, NR3B3)
robustly activated miR-433 and miR-127 promoter
reporters through ERRE, which was transrepressed
bySHP.ThestrongelevationofmiR-433andmiR-127
in Hepa-1 cells correlated with the down-regulation
of SHP and up-regulation of ERRc. Ectopic expres-
sion of ERRc induced miR-433 and miR-127 expres-
sion, which was repressed by SHP coexpression. In
contrast, knockdown ERRc decreased miR-433 and
miR-127 expression. In addition, the ERRc agonist
GSK4716 induced miR-433 and miR-127 expression
bothinvitroandinvivo,respectively.Insummary,the
coupled miR-433 and miR-127 genes were tran-
scribed from independent promoters regulated by
nuclear receptors ERRc/SHP in a compact space by
using overlapping genomic regions.
INTRODUCTION
MicroRNAs have emerged recently as a new class of non-
protein-coding RNA molecules that have been shown to
participate in the regulation of many cellular processes
and changes of their expression are frequently observed
in human diseases (1–3). Since the discovery of miRNAs,
studies have been focused on the function of miRNAs (4,5)
and their post-transcriptional regulation of mRNA targets
(6,7). A major gap exists regarding how the expression
of miRNA genes are regulated by transcription factors
including nuclear receptors. This area of study is particu-
larly challenging because little is known about miRNA
gene structure and their transcriptional initiation sites.
Small heterodimer partner (SHP, NROB2) is a unique
orphan nuclear receptor and transcriptional repressor that
plays important roles in several metabolic diseases and in
liver carcinogenesis (8–11). Due to lack of DNA-binding
domain, SHP is unable to bind directly to its target gene
promoter, but exerts its transrepressive eﬀect through
physical interaction with its regulatory partners (12),
including estrogen related receptor (ERRg, NR3B3)
(8,13). To determine the potential regulatory function of
SHP in miRNA gene expression, we conducted miRNA
expression proﬁling using SHP
–/– mice and cloned the
primary transcripts encoding miR-433 and miR-127 gene
cluster. We for the ﬁrst time revealed that pri-miR-433 and
pri-miR127 were derived from two separate but overlap-
ping genes (manuscript under review). In this study, we
characterized the molecular mechanism that controls miR-
433 and miR-127 gene transcription. Our study showed
that the transcription of miR-433 and miR-127 genes
was tightly regulated by ERRg and SHP through indepen-
dent promoters which used overlapping genomic coding
regions. Our results revealed a novel mechanism by which
the coupled miR-433 and miR-127 genes were regulated
by nuclear receptors in a compact genomic space.
MATERIALS AND METHODS
Total RNA isolation andmiRNA microarrayanalysis
Total RNA with miRNA was isolated from livers of
2-month-old male mice (n=3) using mirVana
TM miRNA
Isolation Kit (Ambion, Austin, TX, USA). The RNA
quality control was performed using Bioanalyzer 2100.
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–/–) and wild-type (WT) mice on a
pure C57/BL6 background were analysed. The mice were
with normal chow diet under feeding conditions.
MiRNA microarray including labelling, hybridization,
image scanning and initial data analysis was carried out
by LC sciences (http://www.LCsciences.com, Houston,
TX). All protocols were deposited at ArrayExpress.
LC-miRHumanMouseRat-9.1-070207-MRA-1030 array
was used which was deposited in MIAMExpress. In brief,
arrays are made based mParaﬂo microﬂuidic technology
(Atactic Technologies, Houston, TX, USA). On the
mParaﬂo microﬂuidic chip, each detection probe consists
of a chemically modiﬁed nucleotide coding segment com-
plementary to target microRNA (from miRBase, http://
microrna.sanger.ac.uk/sequences/) or other RNA (control
or customer deﬁned sequences) and a spacer segment of
polyethylene glycol to extend the coding segment away
from the substrate. The detection probes are made by
in situ synthesis using photogenerated reagent (PGR) chem-
istry (Array Protocol: LC Mir-Array-Prtl-060518). Small
RNAs (<300nt) are 30-extended with a poly(A) tail using
poly(A) polymerase. An oligonucleotide tag is then ligated
to the poly(A) tail for later ﬂuorescent dye staining; two
diﬀerent tags are used for the two RNA samples in dual-
sample experiments (Labeling Protocol: LC Mir-Label
Prtl-060518). Hybridization is performed using a micro-
circulation pump (Atactic Technologies). The hybridization
conditions are 100ml6 SSPE buﬀer (0.90M NaCl, 60mM
Na2HPO4, 6mM EDTA, pH 6.8) containing 25% form-
amide, 348C and overnight (Hybridization Protocol: LC
Mir-Hyb Prtl-060518). Hybridization images are collected
using a laser scanner (GenePix 4000B, Molecular Device,
Sunnyvale, CA, USA). Scan resolution is set at 10m and
PTM is set between 350 and 700V (Scanning Protocol: LC
Mir-Scan Prtl-060518). Data are analysed by ﬁrst subtract-
ing the background and then normalization. The back-
ground is determined using a regression-based background
mapping method. The regression is performed on 5–25%
of the lowest intensity data points excluding blank spots.
Raw data matrix is then subtracted by the background
matrix. Normalization is carried out using a LOWESS
(Locally weighted Regression) method on the background-
subtracted data (Normalization Protocol: LC Mir-Norm
Prtl-060518). The data were deposited to the ArrayExpress
database and the accession number is E-MEXP-1721.
Real-timeRT–PCR quantification of miRNAs
Real-time reverse transcription polymerase chain reaction
(RT–PCR) quantiﬁcation of miRNA expression was car-
ried out using mirVana
TM quantitative real-time PCR
(qRT-PCR) miRNA Detection Kit (Ambion, Austin,
TX, USA) according to manufacturer’s protocol. Brieﬂy,
cDNAs were synthesized from total RNA using gene-
speciﬁc primers. Reverse transcription reactions contained
25ng RNA samples, 1ml of RT primer, 2ml of RT buﬀer
and 0.4ml of ArrayScript Enzyme Mix. The 10ml reactions
were incubated for 30min at 378C, 15min at 958C, then
held at 48C. Real-time PCR was performed using an
Applied Biosystems 7500 sequence detection system. The
25ml PCR included 10ml RT product, 12.5ml of SYBR
green mix (Applied Biosystems, Foster City, CA, USA)
and 0.5 U Super Taq (Ambion) and 0.5ml of mirVana
PCR primers. Reactions were incubated in a 96-well
optical plate at 958C for 10min, followed by 45 cycles of
958C for 15s and 608C for 1min. The threshold cycle (Ct)
was determined using default threshold settings. The
Ct value is deﬁned as the fractional cycle number
at which the ﬂuorescence passes the ﬁxed threshold. All
experiments were done in triplicates and repeated three
times. 5S small RNA was used as an internal control
to normalize microRNA input in the real-time RT–PCR
assay. Data were then analysed using the equation 2 Ct,
where Ct=(Ct, Target–Ct, 5S) Target sample –
(Ct, Target–Ct, 5S) Calculator (14).
In vitro andin vivotreatment of ERRcagonist
ERRg agonist GSK4716 (Cat #: C0926) was obtained
from Sigma. In vitro cell culture experiments with
GSK4716, Hepa-1 cells were treated with diﬀerent doses
of GSK4716 (5, 10 and 20mm) or ethanol (vehicle) for 18h
(ﬁrst time) and 8h (second time). For in vivo i.p. injection
in mice, GSK4716 was made up as a 20% solution
in Cavitron (15). The mice were injected twice with
100mg/kg of GSK4716, and the livers were collected for
miR-433 and miR-127 gene expression analysis.
Transient transfection
The promoters of pri-miR-433 and pri-miR-127 were
cloned into pGL3 basic vector, respectively. Hela cells
were maintained in Dulbecco’s Modiﬁed Eagle’s
Medium in the presence of 10% fetal bovine serum.
Eight additional deletion constructs of pri-miR-127 and
pri-miR-433 promoter reporters were generated using
eight upstream primers (see Supplementary Materials).
All deletion constructions were veriﬁed by sequencing.
SHP and ERRg expression vectors are available in our
laboratory. For luciferase assays, cells were plated in
24-well plates 1day before transfection and transfec-
tion was carried out using Fugene HD (Roche,
Indianapolis, IN, USA). Total DNA in each transfection
was adjusted by adding appropriate amounts of pcDNA3
empty vector. Approximately 48h after transfection, cells
were harvested and luciferase activities were measured and
normalized against b-galactosidase activities as an internal
control. The transfection experiments were carried out
independently three times with similar eﬃciency and one
representative result is shown.
Chromatin immunoprecipitation (ChIP) assays
The ChIP assays were performed using the ChIP Assay
Kit (Upstate Biotechnology, Lake Placid, NY, USA).
Hepa-1 cells were cultured until 70–80% conﬂuence.
Chromatin was cross-linked with 1% formaldehyde at
378C for 10min. Cells were washed with cold PBS twice
and disrupted in SDS lysis buﬀer containing the protein
inhibitor cocktail. Chromatin was sonicated to shear
DNA to an average length between 200 and 1000bp as
veriﬁed by agarose gel. The sonicated cell supernatants
were diluted 10-fold in ChIP dilution buﬀer containing the
protein inhibitor cocktail and an aliquot of the solution
5728 Nucleic Acids Research, 2008, Vol. 36, No. 18was reserved for input control. Ten micrograms of ERRg
antibody (Aviva Systems Biology, San Diego, CA, USA)
was added and the chromatin solution was gently rotated
overnight on ice. The protein A agarose slurry was added
to the antibody-bound chromatin solution and incubated
at 48C for 1h with constant rotation. The agarose beads
were collected by centrifugation, washed and the anti-
body-bound chromatin was released from the agarose
beads. Finally, the DNA was puriﬁed by phenol/chloro-
form extraction and ethanol precipitation. The ERRE
region was detected using primers (see Supplementary
Materials) in PCR reactions. A 10kb region downstream
from the ERRE was selected and detected using primers
listed in the Supplementary Material.
Electrophoretic mobility shiftassay(EMSA)
EMSA was done using the LightShift Chemiluminescent
EMSA Kit from Pierce Biotechnology (Rockford, IL,
USA). In vitro translated ERRg was incubated with the
biotin-labelled duplex oligonucleotide probes (see Supple-
mentary Materials). The binding reactions contained
biotin-labelled DNA were incubated with the in vitro trans-
lated proteins in 1  binding buﬀer and 1mg/ml Poly
(dI dC) for 20min at room temperature. Competitor
oligonucleotides were included at a 10- to 100-fold molar
excess as indicated. DNA–protein complexes were resolved
by electrophoresis in 6% native acrylamide gels and visua-
lized by chemiluminescence.
RNA interference (RNAi)
ShRNA constructs against Mus musculus ERRg were
purchased from Origene Company (Rockville, MD,
USA). Hepa-1 cells were cultured until 70–80% conﬂu-
ence. ShRNA constructs were transfected into the cells
using transfection reagent Fugene HD (Roche) according
to the manufacturer’s instructions. The level of ERRg
expression was determined using real-time PCR.
Adenoviral transduction
Recombinant adenovirus vectors for expression of mSHP
and the GFP control were prepared as described (8). Viral
supernatants were generated by standard methods at
Baylor College of Medicine BCM virus Core facility.
Hepa-1 and Huh7 cells were cultured to 70–80% conﬂu-
ence. They were plated at 2 10
6/10cm dish and infected
the next day with viral supernatant at diﬀerent multipli-
cities of infection for 2h. Virus containing media were
removed and cells were continuously cultured.
RESULTS
MiRNAs microarrayprofiling in SHP
–/– mice
As an initial step to establish a correlation between SHP
and miRNA gene expression, we conducted miRNA
expression proﬁling by miRNA-microarray analysis
using RNAs isolated from livers of WT and SHP
–/–
mice (Figure S1). Gene proﬁling and hierarchical cluster-
ing identiﬁed a total of 143 miRNAs that were diﬀeren-
tially expressed (P<0.01) (Figure 1A-a0 and Table S1).
Among the 143 diﬀerentially expressed miRNAs, 82
were up-regulated and 61 were down-regulated in
SHP
–/– liver relative to the WT control. Out of the 82
up-regulated miRNAs, a surprising co-localization of 21
miRNAs on a single chromosome (Chr 12), that were
arranged in a cluster, was revealed by comparative analy-
sis (Figure 1A-b0 and -c0). The down-regulated miRNAs
were located among diﬀerent chromosomes. The coordi-
nated up-regulation of miRNAs clustered on chromosome
12 in SHP
–/– mice raised the possibility of a common
repressive mechanism by SHP on the expression of these
miRNAs. The expression levels of selected up-regulated
miRNAs were further validated by qPCR using primer–
probe sets that are commercially available (Figure 1B).
The fold increases of miRNA expression in SHP
–/– mice
were generally higher by qPCR analysis as compared with
microarray analysis, consistent with qPCR being a more
sensitivity method for quantitating gene expression.
Cloning of miRNA primary transcripts to determine the
transcriptional initiation sites (TIS) is the ﬁrst step towards
elucidatingtheregulationofmiRNAgeneexpression.Using
database mining method and EST extension, we ﬁrst cloned
theprimarytranscriptsofmiR-433andmiR-127by50 and30
RACE and observed that the expression of both transcripts
was strongly up-regulated in livers of SHP
–/– mice as com-
paredwithWTmice(Song,G.S.andWang,L.,unpublished
data). In addition, the basal expression of pri-miR-127
appeared to be higher than that of pri-miR-433 in SHP
–/–
mice, which was consistent with the expression pattern of
mature miR-433 and miR-127 (Figure 1B).
Cloning miR-433and miR-127 promoters andidentifying
nuclearreceptor-binding elements
Despite similarities in their precursor organization, miR-
433 and miR-127 exhibited an increased, but diﬀerent,
fold induction of expression in SHP
–/– mice (Figure 1B).
This suggests that they share a common inhibited mecha-
nism by SHP, but are independently regulated at the tran-
scriptional level. It is postulated that the region between
the pre-miR-433 TIS and the pri-miR-127 TIS that con-
tains part of pri-miR-433 may function as the promoter
for pri-miR-127. Thus, the promoter of pri-miR-127
is located within the genomic region that encodes pri-
miR-433 (Figure 2).
We cloned the region  1.4–1.5kb upstream from TIS of
pri-miR-433 and pri-miR-127 into luciferase reporters,
respectively. Sequence analysis of the miR-433 and miR-
127 promoters with the MatInspector program predicted
two potential binding sites ( 647/ 656nt and  1271/
 1280nt from TIS of miR-433;  375/ 384nt and  894/
 903nt from TIS of miR-127) for the ERRg (Table 1).
Putative binding sites for farnesoid X receptor (FXR)
and peroxisome proliferator-activated receptor (PPAR)
were also identiﬁed in the miR-433 promoter (Table 2).
Common regulationof miR-433 andmiR-127 promoters
by nuclearreceptors ERRc/SHP
To explore the mechanisms of nuclear receptor regula-
tion of miR-433 and miR-127 expression, transient
transfection assays were performed. Among the nuclear
Nucleic Acids Research, 2008, Vol. 36, No. 18 5729receptors tested, ERRg (Eg), but not LXR (L), TR (T),
ER (E), CAR (C), PPARa (Pa), PPARb (Pb) and ERRa
(Ea), robustly stimulated the transactivation of both the
miR-433 and miR-127 promoter reporters (Figure 3A).
Ectopic expression of FXR/RXRa (FR), PPARa/RXRa
(PaR) and PPARg/RXRa (PgR) heterodimers also
moderately activated the miR-433Luc, but not miR-
127Luc. As expected, the response of the miR-433Luc
and miR-127Luc to ERRg was dose-dependent and was
strongly repressed by SHP coexpression (Figure 3B),
Poly A
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Pre-miR-433 Pre-miR-127
miR-433 promoter
miR-127
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Figure 2. Schematic of the overlapping miR-433 and miR-127 gene structure and the location of nuclear receptor-binding sites in the miR-433 and
miR-127 promoters.
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Figure 1. Analysis of miRNA expression in the livers of WT and SHP
–/– mice. (A-a0) Hierarchical clustering of miRNA expression proﬁling by
microarray analysis. (A-b0) Hierarchical clustering of the 21 upregulated miRNAs in SHP
–/– mice as compared with WT mice. (A-c0) The 21 up-regulated
miRNAs in SHP
–/– mice formed a cluster on the chromosome 12. (B) Real-time PCR veriﬁcation of the miRNA expression in WT and SHP
–/– mice.
5730 Nucleic Acids Research, 2008, Vol. 36, No. 18consistent with ERRg being a target for potent SHP
repression (8,13).
The ERR elements were designated as E1 and E2 for
the miR-433Luc, E10 and E20 for the miR-127Luc
(Figure 3C). Inactivation of E2 by deletion the entire
ERRE site markedly decreased miR-433 (-1088) Luc
activity induced by low (empty bar) and high (ﬁlled bar)
doses of ERRg (left). The eﬀect of deleting both E1/E2
(-622 and -328Luc) appeared to be no diﬀerent than that
of deleting E2 alone (-1088Luc), whereas the activity of
the smallest -92Luc was further decreased. Serial deletion
of E20 and its surrounding region reduced miR-127 (-990,
-713 and -508) Luc activity induced by low doses but not
by high doses of ERRg (right). Further deletion of E10
signiﬁcantly decreased -287Luc transactivation. Thus,
E2 in the miR-433 promoter and E10/E20 in the miR-127
promoter appeared to be potent ERRE sites for ERRg
activation. It is noted that deletion both of E1/E2
or E10/E20 did not completely block transactivation of
either promoter to the basal level, suggesting additional
mechanisms for the regulation of the miR-433 and
miR-127 promoters.
ChIP analyses showed that ERRg was physically asso-
ciated with the endogenous miR-433 and miR-127 promo-
ters in Hepa-1 cells by strong Co-IP at E2 and E10 sites,
respectively (Figure 4A). In contrast, a non-speciﬁc primer
set located  11kb downstream of miR-127 promoter did
not produce PCR product. In addition, RNAi knockdown
ERRg in the cells markedly reduced ERRg binding to the
promoters. It has been reported that ERRg can activate
ERRa promoter through an ERRE (16). Thus, ChIP
assays were performed on ERRa promoter, which
served as a positive control. As shown in Figure 4A
(lower panel), ERRg was Co-IP on ERRa promoter
using ERRg antibodies. Taken together, the results sup-
port our conclusion that ERRg can bind to the endogen-
ous miR-433 and miR-127 promoters in Hepa-1 cells.
EMSA showed that the ERRg protein eﬃciently bound
to E2, E10 and E20, but not E1 (Figure 4B). Thus,
E1 appeared to be a non-speciﬁc ERRE. These results
identiﬁed ERRg and SHP as potent transcriptional regu-
lators of miR-433 and miR-127 promoter activity.
Regulation of miR-433and miR-127 expression
by ERRc/SHP
To test the direct regulatory eﬀects of ERRg and SHP
on miR-433 and miR-127 expression, mouse hepatoma
Hepa-1 cells, which have lost SHP expression (11), were
used. Increased expression of ERRg (Figure 5A, left) and
ERRb (Figure S2A), but not ERRa, correlated with the
up-regulation of miR-433 and miR-127, as compared
with normal hepatocyte Nmuli cells (Figure 5A, right).
Despite increased expression of ERRb in Hepa-1 cells,
luciferase activity with the miR-433 and miR-127 promo-
ter constructs was rather weak, thus we consider it as
non-responsive (Figure S2B). Thus, ERRb is an unlikely
regulator of miR-433 and miR-127 expression. Ectopic
overexpression of ERRg in Hepa-1 cells signiﬁcantly
induced both miR-433 and miR-127 expression, which
was repressed by coexpression of SHP (Figure 5B).
Knocking down ERRg in Hepa-1 cells by siRNA
(Figure S2C) resulted in a corresponding reduction of
miR-127 expression, although the eﬀect on miR-433 was
somewhat less eﬃcient (Figure 5C). The data suggest
that the transcription of the miR-433 gene may also be
regulated by other nuclear receptors, as indicated by the
transfection results (Figure 3A).
GSK4716 has been reported to be a selective ERRg
agonist which enhances ERRg activity (15). Indeed,
the transactivation of ERRg on miR-433Luc and miR-
127Luc containing ERRE was markedly enhanced by
GSK4716 (Figure 5D), whereas no or weak activation
on -92miR-433Luc and -287miR-127Luc was observed,
respectively. Co-transfection of SHP dose-dependently
inhibited the eﬀect of GSK4716 on ERRg activity
(Figure 5E). Consistently, activation of ERRg by GSK
4716 induced miR-433 expression in a dose-dependent
manner (Figure 6A, a0). The lack of dose response for
the miR-127 suggested that miR-127 gene may be more
Table 1. Predicted ERR binding sites on the miR-433 and miR-127 gene promoters
miR-433 Promoter (from miR-433-TIS) miR-127 Promoter (from miR-127-TIS)
ERRE1: TGAAGGTgA ( 647 to  656) ERRE1: ACAAGGTCA ( 375 to  384)
ERRE2: cCAAGGTCA ( 1271 to  1280) ERRE2: TcACCTTCA ( 894 to  903)
The predicted hits were mainly ﬁltered out based on the criteria of Core Similarity 1 and a Matrix similarity
of more than 0.8. For ERRE sites, mismatches with the consensus sequence are indicated by lower case letters.
Table 2. Predicted binding sites for NRs on the miR-433 gene promoter
TF name Optimized matrix
threshold
Strand Core similarity Matrix similarity Sequence
(capitals: core sequence)
Farnesoid X - activated receptor
(RXR/FXR dimer), IR1 sites
0.8 (+) 1 0.884 AGGTcagtgtccc
Farnesoid X - activated receptor
(RXR/FXR dimer), IR1 sites
0.8 (+) 0.875 0.8 GGGTcactggcat
PPAR/RXR heterodimers, DR1 sites 0.76 ( ) 0.753 0.764 cccagccagggaacAGGCaaggc
The NR-binding sites on the promoter regions of the two primary transcripts were predicted using software MatInspector. The predicted hits were
mainly ﬁltered out based on the criteria of Core Similarity 1 and a Matrix similarity of more than 0.8.
Nucleic Acids Research, 2008, Vol. 36, No. 18 5731sensitive to GSK4716 and that the lowest dose of
GSK4716 that we used may have induced a maximal
response (b0). Indeed, a dose-responsive activation
of miR-127 was observed when a low dose range
of GSK4716 was applied (c0). To conﬁrm the eﬀect of
GSK4716, we analysed ERRg target gene ERRa mRNA
expression (16). GSK4716 treatment induced ERRa
expression in both the Hepa-1 and Nmuli cells
(Figure 6A, d0). When administrated in vivo in mice,
GSK4716 induced miR-433 expression to a similar
extent in both the WT and SHP
–/– mice (Figure 6B, left).
Interestingly, the induction of miR-127 by GSK4716
was more dramatic in WT than in SHP
–/– (right). It is
possible that the expression of ERRg mRNA (not
shown) and miR-127 (Figure 1B) was already highly
up-reguated in SHP
–/– mice, and that GSK may not
be able to further enhance ERRg activity. In addition,
the expression of ERRa was induced by GSK4716
in both the WT and SHP
–/– mice (Figure 6C), further
conﬁrm the eﬀect of GSK4716.
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Figure 3. Promoter analysis of the miR-433 and miR-127 luciferase reporters. (A) Transient transfection assays to determine nuclear receptor
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inactivation of the putative ERRE sites in the miR-433 (E1 and E2) and miR-127 (E10 and E20) promoter reporters. Each deletion reporter was
transfected with the ERRg expression plasmid (white bar, 20ng; black bar, 40ng) and luciferase activities were determined and normalized.
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Recently, emerging studies have established molecular
links between miRNAs and nuclear receptors (17–20).
However, essentially all these studies have focused on
miRNA regulation of post-transcription of nuclear recep-
tors. Although in one report it was shown that the expres-
sion of several miRNAs was altered in nuclear receptor
PPARa knockout mice, the transcriptional mechanism of
how PPARa regulates these miRNAs remains unknown
(20). Our study is the ﬁrst report which characterized
the detailed molecular basis for SHP/ERRg controlling
miR-433 and miR-127 expression.
It is noted that the clustered 21 miRNAs on chromo-
some 12 were all up-regulated in SHP
–/– mice, suggesting
that they were directly or indirectly suppressed by SHP.
Because we have not cloned all the primary transcripts
and promoters for these up-regulated miRNAs, it is cur-
rently unknown if these clustered miRNAs are regulated
through SHP/ERRg dependent mechanism or through
SHP dependent but ERRg independent mechanism. It
would be of great interest to investigate in future studies.
A recent report suggests that the human miR-127 is
expressed as part of a miRNA cluster including miR-433
and is processed from a large transcript including all
miRNAs (21). Our data show that the mouse miR-127
and miR-433 are generated from two distinct but overlap-
ping primary transcripts controlled by independent pro-
moters. Our new preliminary data suggest that a similar
regulatory mechanism exists in other mammalian species
including humans (Song, G.S. and Wang, L., unpublished
data). Therefore, miR-433 and miR-127 expression regu-
lation that we identiﬁed in mice may represent a conversed
mechanism in a variety of mammalian species.
One interesting question is whether the elements
upstream of miR-433 may also regulate miR-127.
Eukaryotic gene promoters can have regulatory elements
in proximal region or several kilobases away from the
transcriptional start site. In general, the proximal promo-
ter contains primary regulatory elements and the distal
promoter may contain additional regulatory elements,
often with a weaker inﬂuence than the proximal promoter.
It is possible that the ERREs upstream of the miR-433
TIS start site may also regulate miR-127. Because the sites
are over 2kb away from the TIS of pri-miR127, they may
represent weak regulatory elements. Therefore, miR-127 is
believed to be primarily regulated by the proximal ERREs
between miR-433 TIS and miR-127 TIS. Nevertheless, the
results, that the two pri-miRNAs produced from the miR-
433-127 locus are transcribed from two separate over-
lapping genes and the basal expression of pri-miR-127
is much higher than pri-miR-433, strongly suggest that
miR-127 and miR-433 are independently and diﬀerentially
regulated.
Another question is whether the ERREs in the promo-
ters of miR-433 or miR-127 may also contribute to the
increased expression of the ﬂanking miR-431 and miR-
343-3p/5p. The question is expected to be addressed
upon determining TIS and TTS of both miRs and the
cloning of full-length pri-miR-431 and pri-miR-343.
SHP has been recently shown to function as a tumour
suppressor in liver cancer (10,11). It remains to be deter-
mined if miR-127 regulates BCL-6 in HCC, as it does in
other human cancer cells (21). A direct association
between SHP, miR-127 and HCC progression is currently
under investigation.
In summary, our identiﬁcation of the common regula-
tion of miR-433 and miR-127 gene transcription by the
nuclear receptors SHP and ERRg and potential diﬀeren-
tial regulation of miR-433 by other nuclear receptors
support the notion of a complex and interactive regulation
of miRNA gene expression.
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